Futura Medical plc

AIM:FUM Stock Report

Market Cap: UK£107.2m

Futura Medical Management

Management criteria checks 1/4

Futura Medical's CEO is James Barder, appointed in Jun 2001, has a tenure of 22.83 years. total yearly compensation is £435.06K, comprised of 57.8% salary and 42.2% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth £505.16K. The average tenure of the management team and the board of directors is 9.8 years and 2.5 years respectively.

Key information

James Barder

Chief executive officer

UK£435.1k

Total compensation

CEO salary percentage57.8%
CEO tenure22.8yrs
CEO ownership0.5%
Management average tenure9.8yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Apr 17
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

Jul 28
Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

Mar 18
We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Sep 25
We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Jan 10
We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Dec 21
What We Learned About Futura Medical's (LON:FUM) CEO Compensation

CEO Compensation Analysis

How has James Barder's remuneration changed compared to Futura Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-UK£7m

Sep 30 2023n/an/a

-UK£6m

Jun 30 2023n/an/a

-UK£5m

Mar 31 2023n/an/a

-UK£5m

Dec 31 2022UK£435kUK£251k

-UK£6m

Sep 30 2022n/an/a

-UK£6m

Jun 30 2022n/an/a

-UK£6m

Mar 31 2022n/an/a

-UK£5m

Dec 31 2021UK£357kUK£243k

-UK£5m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021n/an/a

-UK£3m

Dec 31 2020UK£309kUK£243k

-UK£2m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£6m

Mar 31 2020n/an/a

-UK£7m

Dec 31 2019UK£238kUK£236k

-UK£9m

Sep 30 2019n/an/a

-UK£9m

Jun 30 2019n/an/a

-UK£8m

Mar 31 2019n/an/a

-UK£7m

Dec 31 2018UK£276kUK£230k

-UK£6m

Sep 30 2018n/an/a

-UK£5m

Jun 30 2018n/an/a

-UK£4m

Mar 31 2018n/an/a

-UK£4m

Dec 31 2017UK£235kUK£230k

-UK£4m

Compensation vs Market: James's total compensation ($USD541.62K) is above average for companies of similar size in the UK market ($USD345.35K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.

CEO

James Barder (64 yo)

22.8yrs

Tenure

UK£435,059

Compensation

Mr. James Henry Barder has been the Chief Executive Officer of Futura Medical PLC since April 2001. Mr. Barder was first involved with Futura Medical Plc as an investor in 1997. Previously, he served as Ma...

Leadership Team

NamePositionTenureCompensationOwnership
James Barder
CEO & Executive Director22.8yrsUK£435.06k0.47%
£ 505.2k
Angela Hildreth
COO, Finance Director6.2yrsUK£310.80k0.047%
£ 50.8k
Kenneth James
Head of R&D & Executive Director7.4yrsUK£284.59k0.099%
£ 106.5k
William Potter
Chief Scientific Officer & Adviser to the Board12.2yrsUK£29.83kno data
Graham Smith
Head of Alliance Partnerships & Supplyno datano datano data
Kevin Langridge
Head of Qualityno datano datano data

9.8yrs

Average Tenure

67.5yo

Average Age

Experienced Management: FUM's management team is seasoned and experienced (9.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Barder
CEO & Executive Directorno dataUK£435.06k0.47%
£ 505.2k
Angela Hildreth
COO, Finance Director6.2yrsUK£310.80k0.047%
£ 50.8k
Kenneth James
Head of R&D & Executive Director8yrsUK£284.59k0.099%
£ 106.5k
Gordon Davis
Non-Executive Directorless than a yearno datano data
Andrew Unitt
Senior Independent Non-Executive Director2.3yrsUK£50.00k0.0088%
£ 9.4k
Jeffrey Needham
Independent Non-Executive Chairman2.5yrsUK£53.13k0.0054%
£ 5.8k

2.5yrs

Average Tenure

66.5yo

Average Age

Experienced Board: FUM's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.